Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 1
2000 1
2002 1
2006 2
2007 1
2008 1
2009 2
2011 3
2012 2
2013 2
2014 3
2015 4
2016 4
2017 2
2018 3
2019 2
2020 6
2021 5
2022 5
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Modern radiation therapy for primary cutaneous lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group.
Specht L, Dabaja B, Illidge T, Wilson LD, Hoppe RT; International Lymphoma Radiation Oncology Group. Specht L, et al. Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):32-9. doi: 10.1016/j.ijrobp.2015.01.008. Int J Radiat Oncol Biol Phys. 2015. PMID: 25863751 Free article.
Radiation therapy of primary cutaneous lymphomas requires the use of special techniques that form the focus of these guidelines. ...The guidelines represent an agreed consensus view of the International Lymphoma Radiation Oncology Group steering committee on the use …
Radiation therapy of primary cutaneous lymphomas requires the use of special techniques that form the focus of these guidelines. ...T …
Diagnosis and management of ALK-positive anaplastic large cell lymphoma in children and adolescents.
Rigaud C, Knörr F, Brugières L, Woessmann W. Rigaud C, et al. Best Pract Res Clin Haematol. 2023 Mar;36(1):101444. doi: 10.1016/j.beha.2023.101444. Epub 2023 Feb 2. Best Pract Res Clin Haematol. 2023. PMID: 36907641 Review.
Anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL) is a CD30-positive T cell lymphoma characterized by signalling from constitutively activated ALK fusion proteins. Most children and adolescents …
Anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL) is a CD30-positive …
Management of Peripheral T-cell Lymphomas and the Role of Transplant.
Foley NC, Mehta-Shah N. Foley NC, et al. Curr Oncol Rep. 2022 Nov;24(11):1489-1499. doi: 10.1007/s11912-022-01310-3. Epub 2022 Aug 10. Curr Oncol Rep. 2022. PMID: 35947286 Free PMC article. Review.
PURPOSE OF REVIEW: Here, we review the management of peripheral T-cell lymphoma, particularly focusing on the role of autologous and allogeneic stem cell transplant. ...For patients with peripheral T-cell lymphoma able to achieve sufficient dise …
PURPOSE OF REVIEW: Here, we review the management of peripheral T-cell lymphoma, particularly focusing on the role of autologo …
2022 Practice Recommendation Updates From the World Consensus Conference on BIA-ALCL.
Santanelli di Pompeo F, Clemens MW, Atlan M, Botti G, Cordeiro PG, De Jong D, Di Napoli A, Hammond D, Haymaker CL, Horwitz SM, Hunt K, Lennox P, Mallucci P, Miranda RN, Munhoz AM, Swanson E, Turner SD, Firmani G, Sorotos M. Santanelli di Pompeo F, et al. Aesthet Surg J. 2022 Oct 13;42(11):1262-1278. doi: 10.1093/asj/sjac133. Aesthet Surg J. 2022. PMID: 35639805 Free PMC article. Review.
BACKGROUND: Laboratory and clinical research on breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is rapidly evolving. Changes in standard of care and insights into best practice were recently presented at the 3rd World Consens …
BACKGROUND: Laboratory and clinical research on breast implant-associated anaplastic large cell lymphoma (BIA-AL …
Moving towards biologically informed treatment strategies for T-cell lymphomas.
Stuver R, Lewis N, Dogan A, Horwitz SM. Stuver R, et al. Int J Hematol. 2023 Apr;117(4):492-503. doi: 10.1007/s12185-022-03524-4. Epub 2022 Dec 27. Int J Hematol. 2023. PMID: 36574170 Free PMC article. Review.
The rarity and biological heterogeneity of the peripheral T-cell lymphomas has made subtype- and biomarker-driven approaches challenging to realize and even more challenging to evaluate in clinical practice. Out of necessity, treatment of T-cell lymphomas has histor …
The rarity and biological heterogeneity of the peripheral T-cell lymphomas has made subtype- and biomarker-driven approaches challeng …
Cutaneous manifestations and management of hematologic neoplasms.
Oluwole OO, Zic JA, Douds JJ, Ann Thompson M, Greer JP. Oluwole OO, et al. Semin Oncol. 2016 Jun;43(3):370-83. doi: 10.1053/j.seminoncol.2016.02.021. Epub 2016 Feb 23. Semin Oncol. 2016. PMID: 27178691 Review.
The majority of lymphomas that directly infiltrate the skin are of T-cell origin but B-cell lymphomas, and other hematologic neoplasms, including acute myeloid and lymphoblastic leukemias, can also have cutaneous involvement, whereas some have an indolent course, eg …
The majority of lymphomas that directly infiltrate the skin are of T-cell origin but B-cell lymphomas, and other hematologic n …
Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Updated Systematic Review and Analysis of Treatment Strategies.
Naga HI, Mellia JA, Basta MN, Morris MP, Christopher AN, Campbell FM, Sommers K, Levinson H, Nelson JA, Fischer JP. Naga HI, et al. Plast Reconstr Surg. 2022 Oct 1;150(4):762-769. doi: 10.1097/PRS.0000000000009538. Epub 2022 Jul 22. Plast Reconstr Surg. 2022. PMID: 35862104 Free PMC article.
BACKGROUND: Although guidelines have been published on treatment of breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL), there has been no comprehensive analysis of BIA-ALCL treatment variation based on the available literature. ...Prac …
BACKGROUND: Although guidelines have been published on treatment of breast implant-associated anaplastic large-cell …
Management of relapsed or refractory hodgkin lymphoma with second-generation antibody-drug conjugates: focus on brentuximab vedotin.
Mei M, Thomas S, Chen R. Mei M, et al. BioDrugs. 2014 Jun;28(3):245-51. doi: 10.1007/s40259-013-0077-7. BioDrugs. 2014. PMID: 24258497 Free PMC article. Review.
It has demonstrated significant activity in CD 30-positive lymphomas and is currently approved by the US FDA for treatment of Hodgkin lymphoma that has relapsed following autologous stem-cell transplantation, or after two lines of chemotherapy in non-transplant cand …
It has demonstrated significant activity in CD 30-positive lymphomas and is currently approved by the US FDA for treatment of Hodgkin lym …
Current management of primary cutaneous CD30+ T-cell lymphoproliferative disorders.
Kadin ME. Kadin ME. Oncology (Williston Park). 2009 Nov 30;23(13):1158-64. Oncology (Williston Park). 2009. PMID: 20043465 Free article. Review.
Primary cutaneous CD30+ T-cell lymphoproliferative disorders (PCLPDs) are the second most common type of cutaneous T-cell lymphoma. These disorders comprise a spectrum of clinically benign lymphomatoidpapulosis (LyP) and primary cutaneous anaplastic …
Primary cutaneous CD30+ T-cell lymphoproliferative disorders (PCLPDs) are the second most common type of cutaneous T-cell l …
Brentuximab vedotin for treatment of non-Hodgkin lymphomas: A systematic review.
Berger GK, McBride A, Lawson S, Royball K, Yun S, Gee K, Bin Riaz I, Saleh AA, Puvvada S, Anwer F. Berger GK, et al. Crit Rev Oncol Hematol. 2017 Jan;109:42-50. doi: 10.1016/j.critrevonc.2016.11.009. Epub 2016 Nov 21. Crit Rev Oncol Hematol. 2017. PMID: 28010897 Free PMC article. Review.
BACKGROUND: Brentuximab vedotin (BV) is an antibody-drug conjucate (ADC) comprising a CD30-directed antibody, conjugated to the microtubule-disrupting agent MMAE via a protease cleavable linker. BV is FDA approved for use in relapsed classical Hodgkin lymphoma (HL) and rel …
BACKGROUND: Brentuximab vedotin (BV) is an antibody-drug conjucate (ADC) comprising a CD30-directed antibody, conjugated to the microtubule- …
47 results